DISRUPTION, REVOLUTION
Should
you edit your children’s genes? Ruthie Weiss’s basketball team seemed to be
minutes away from its fourth straight loss. But even as she stood on the
sidelines for a brief rest, the nine-year-old had not given up. She convinced the coach to
pu…
tags: Pocket
weeklylinks
For
less than $1,000 you can now pull up your entire genome on your smartphone
Veritas Genetics was one of the first companies to sequence the entire human
genome for less than $1,000 in 2015. It’s now taken that technology a
step further by deliver…
tags: Pocket
weeklylinks
Big
Data Meets Big Science in San Diego on March 31: The Agenda In less than a Diego
to talk about the opportunities that are emerging for tech and software
innovation …
tags: Pocket
weeklylinks
TOOLS/TECHNIQUES
When
restrictions come in the form of paperwork and approvals, we detest them.
Whereas, when the restrictions come in the form of enzymes, we love them, don’t
we? Restriction enzymes play a key role in biotechnology research. Read ahead…
HEALTH/MEDECINE
tags: weeklylinks
tags: weeklylinks
o The
federal Medicare
program and private health insurers waste nearly $3 billion every year buying cancer
medicines that are thrown out because many drug makers distribute the drugs
only in vials that hold too much for most patients, a group of cancer
researchers has found.
The
expensive drugs are usually injected by nurses working in doctors’ offices and
hospitals who carefully measure the amount needed for a particular patient and
then, because of safety concerns, discard the rest.
COMPANIES
Illumina
CEO Flatley To Step Aside, deSouza To Take Reins in July Illumina helped usher
in the genomic age. Now the company has a new leader. Illumina (NASDAQ: ILMN)
today said CEO Jay Flatley would step aside in July after 17 years at the helm,
but…
tags: Pocket
weeklylinks
Bio-Rad
get the go-head to market Droplet Digital PCR in Europe In the race to develop
rapid, highly sensitive cancer diagnostics that can detect the disease when it
is little more than a suspicion of rogue cells in the blood stream, liquid
biopsies…
tags: Pocket
weeklylinks
Illumina
CEO Jay Flatley Built The DNA Sequencing Market. Now He's Stepping Down Jay
Flatley is stepping down as chief executive of Illumina, the largest maker of
the DNA sequencing machines that have transformed the study of biology and the
inventi…
SOMETHING DIFFERENT
tags: weeklylinks
- What is most interesting about the Echo is that it came out of nowhere. It isn’t much to look at, and even describing its utility is difficult. Here is a small, stationary machine that you set somewhere in your house, which you address as Alexa, which performs a variety of tasks — playing music, reading the news and weather, keeping a shopping list — that you can already do on your phone.
- Women (who invest) in tech: a list of some of the most influential European female VCs - Tech.eu
Women
(who invest) in tech: a list of some of the most influential European female
VCs Last year in March, Ellen Pao’s high-profile gender discrimination trial
against her former employer – Kleiner Perkins Caufield & Byers – started a
wide conversat…
tags: Pocket
weeklylinks
No comments:
Post a Comment